Clinical Trials Logo

Mental Disorders clinical trials

View clinical trials related to Mental Disorders.

Filter by:

NCT ID: NCT00714818 Completed - Schizophrenia Clinical Trials

Impact of Genetic Counseling for Female First Degree Relatives of Individuals With Mental Illness

Start date: August 2008
Phase: Phase 3
Study type: Interventional

Women with a close relative who has experienced mental illnesses like schizophrenia, bipolar disorder or schizoaffective disorder often have a poor understanding of the causes of the illness, and are often very worried about the chance that any children that they have will become affected with the same illness. Often, because of this fear, these healthy women choose not to have children. Genetic counseling is a process where information about the causes of illnesses, and about chances for family members of individuals with these illnesses to become similarly affected is provided in a supportive environment by a specially trained healthcare professional. This study will investigate whether genetic counseling can reduce perceptions of risk and stigma, and increase perceived control and knowledge about the causes of the illness, amongst women who have a first degree relative with a major mental illness.

NCT ID: NCT00713804 Completed - Schizophrenia Clinical Trials

Impact of Genetic Counseling for Individuals With Mental Illness

Start date: July 2008
Phase: Phase 3
Study type: Interventional

People who have experienced mental illnesses like schizophrenia, bipolar disorder or schizoaffective disorder often have a poor understanding of the causes of their illness, and that they are often very worried about how the illness affects their families. In particular, affected individuals worry that there is a high chance that any children that they have will become affected with the same illness. Often, because of this fear, affected individuals choose not to have children. Genetic counseling is a process where information about the causes of illnesses, and about chances for family members of individuals with these illnesses to become similarly affected is provided in a supportive environment by a specially trained healthcare professional. This study will investigate whether genetic counseling can reduce perceptions of risk and stigma, and increase perceived control and knowledge about the causes of the illness, amongst individuals who have a major mental illness.

NCT ID: NCT00709345 Completed - Mental Illness Clinical Trials

Behavioral Intervention to Reduce Novel Antipsychotic Medication Health Risks

Start date: July 2006
Phase: Phase 1/Phase 2
Study type: Interventional

This study will evaluate the effectiveness of a cognitive behavioral treatment in reducing significant medical risk factors often associated with people who have a serious mental illness and are taking atypical antipsychotic medications.

NCT ID: NCT00709202 Completed - Schizophrenia Clinical Trials

Efficacy and Tolerability Study of Betahistine to Ameliorate Antipsychotic Associated Weight Gain

Start date: July 2008
Phase: Phase 2
Study type: Interventional

The study attempts to evaluate a histamine analog long used for the treatment of Meniere's disease, betahistine, that shows promise in reversing the antihistaminergic effects thought to be involved in antipsychotic induced weight gain. Hypothesis to be tested: A. Patients who have gained a developmentally inappropriate amount of weight on antipsychotics (AP) will see their weight and BMI decrease with betahistine augmentation as compared to placebo augmentation. B. Betahistine augmentation in AP treated patients will increase levels of satiety in a standardized meal situation and decrease caloric intake as compared to placebo augmentation. C. Metabolic effects of betahistine augmentation in AP treated patients will be reflected in differences in waist circumference, hip circumference and waist hip ratios D. Betahistine augmentation in this population will lead to decrease in fasting glucose-lipid lab values related to the development of metabolic syndrome as compared to placebo augmentation

NCT ID: NCT00708994 Completed - Psychotic Disorders Clinical Trials

Cannabinoids, Neural Synchrony, and Information Processing

THC-Gamma
Start date: February 25, 2008
Phase: Early Phase 1
Study type: Interventional

The study examines the effects of delta-9-tetrahydrocannabinol (Δ9-THC), the principal active ingredient of cannabis, on neural synchrony. Neural synchrony is studied using electroencephalography (EEG).

NCT ID: NCT00702793 Withdrawn - Schizophrenia Clinical Trials

Safety and Tolerability of Varenicline in Schizophrenia (SATOVA)

Start date: April 2008
Phase: Phase 4
Study type: Interventional

This is a 15 week trial to determine (1) the safety and tolerability of varenicline when used for smoking cessation/reduction in individuals with schizophrenia; (2) if treatment with varenicline affects the symptoms of schizophrenia.

NCT ID: NCT00692081 Completed - Mental Disorders Clinical Trials

Social Competence Training for Adolescents With Borderline Intellectual Functioning

SCT-ABI
Start date: n/a
Phase: Phase 2/Phase 3
Study type: Interventional

Emotional and behavioural problems as well as a lack of social competence are supposed to be common phenomena in adolescents with borderline intellectual functioning, consequently impairing their social and vocational integration. Considering the lack of evaluated group interventions for this population, a cognitive-behavioural training is developed and its effectiveness is examined in a population of students attending special vocational schools. 77 adolescents with borderline intelligence are enrolled participated in the study. They are randomized either to the intervention group, who received 9 group sessions over a period of 3 months additionally to the standard vocational training (Social Competence Training for Adolescents with Borderline Intelligence, SCT-ABI) or to the control group who received only the standard vocational training. Outcome measures at the end of the intervention and at a 6-months follow-up assessment comprise self-reports, caregiver-reports, and behavioural observations of cognitive, emotional, and behavioural factors of social competence.

NCT ID: NCT00691535 Completed - Depressive Disorder Clinical Trials

Genetics of Symptomatology and Treatment Response in Psychotic Major Depression

Start date: October 2003
Phase:
Study type: Observational

We hope to learn more about the biology of psychiatric illness with the hope of improving the diagnosis and treatment of such psychiatric conditions as major depression.

NCT ID: NCT00690326 Completed - Clinical trials for Type 2 Diabetes Mellitus

Behavioral Change Communication (BCC) to Promote Physical Activity Among Females With Type 2 Diabetes Mellitus Attending Diabetic Clinic

BCC
Start date: May 2006
Phase: N/A
Study type: Interventional

Type 2DM is present in the populations of almost all the countries in the world and is a significant disease burden in most countries .Evidences suggest that population in India develop Type 2 DM at an increasing rate as they reject their traditional life styles. Awareness and knowledge regarding Diabetes and role of physical inactivity in producing complications is still grossly inadequate( Mohan. D, Raj.D Awareness and knowledge of Diabetes in Chennai.The Chennai urban Rural Epidemiology study(CURES-9)J Assoc. Physicians India 2005 April;53:283-7).Exercise is a low cost , non pharmacological intervention that has been shown to be effective in metabolic control. Exercise is still vastly under-utilized in the management of Type 2 DM. Most proximal behavioral cause of insulin resistance is physical inactivity.(Michael J. LaMonte, Steven N. Blair et al.( Physical activity and Diabetes prevention J Appl Physiol. 99: 1205-1213,2005) This study was designed to promote physical activity among type 2 DM female subjects aged 35-65 yrs attending Diabetic clinic of a tertiary care hospital in Kerala.

NCT ID: NCT00690196 Active, not recruiting - Mental Disorders Clinical Trials

Tai Chi Effects on Chronic Insomnia in Breast Cancer Survivors: Immune Mechanisms

Start date: March 2008
Phase: N/A
Study type: Interventional

Breast Cancer is the most common cancer in women. After completion of successful therapy, may behavioral symptoms persist with over 20% of breast cancer survivors reporting chronic insomnia of greater than 6 months duration that fulfils clinical diagnostic criteria with associated functional limitations, decreased quality of life, and possible effects on long-term survival. Behavioral interventions are highly efficacious in the treatment of insomnia and preferred over hypnotic medication when insomnia is chronic. However, insomnia studies conducted in cancer are scarce. The proposed research builds upon program of study that has examined the efficacy of mind-body intervention, Tai Chi Chih (TCC), on health outcomes including sleep impairments. Preliminary studies show that TTC, a slow moving meditation, contributes to improvement in subjective sleep quality, sleep amounts and sleep efficiency. The investigators have further found that sleep, fatigue and proinflammatory cytokine activity are reciprocally related and that TCC decreases the mechanism through TCC carries its effects on sleep outcomes.